Brief: Theraclion announces progress towards market access for Echopulse in the U.S.

Theraclion SA

26/10/2017 07:01

Oct 26 (Reuters) - THERACLION SA  ALTHER.PA  
    * THERACLION MAKES SUBSTANTIAL PROGRESS TOWARDS MARKET 
ACCESS FOR ECHOPULSE IN THE US 
    * PIVOTAL TRIAL FOR BREAST FIBROADENOMA AT OVER 25% 
TREATMENT COMPLETION: 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw2FRrb6a 
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))